NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neuromedical

Neuromedical

Private
PolandHealthcare & Life Scienceshttps://neuromedical.pl/

Last Round

Seed

Feb 17, 2026

Total Funding Raised

$2.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Neuromedical is a medical device company that develops VGuard, a non-invasive transcutaneous vagus nerve stimulation system designed for the treatment of mild cognitive impairment and early-stage Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware + Subscription

AI Layer

Non-AI

Keywords

neuromodulationtranscutaneous vagus nerve stimulationtVNSAlzheimer's treatmentmild cognitive impairmentMCIat-home therapyhardware-as-a-serviceHaaSmedical devicedigital healthremote patient monitoringbrain techneurotechnon-invasive stimulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuromedical Comps

Public and private peers based on sector, stage, and business model.

Neuromedical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neuromedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 17, 2026
SeedMay 20, 2025
SeedMay 17, 2020

Neuromedical Investors

Notable investors and investment history

Neuromedical investors
InvestorRounds
INNOventureSeed
Hard2beatSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2026

    Raised $1.54M in a Seed round.

Neuromedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuromedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuromedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersPoland
Employee Range-
Year Founded2016
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.